Ketamine HCl Prolonged Release Oral Tablets for CRPS
NCT06419985
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
65
Enrollment
OTHER
Sponsor class
Conditions
Complex Regional Pain Syndromes
Interventions
DRUG:
80mg/day Ketamine HCl Prolonged Release
DRUG:
160mg/day Ketamine HCl Prolonged Release
Sponsor
University of Southern California